NASDAQ:CNTG
Centogene N.V. Stock News
$0.380
-0.0200 (-5.00%)
At Close: May 16, 2024
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
11:53am, Thursday, 23'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns
Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress
10:30am, Thursday, 23'rd Apr 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 23, 2020 -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms.
Centogene Reports Financial Results For Full Year 2019 and Highlights Recent Progress
10:30am, Thursday, 23'rd Apr 2020
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 23, 2020 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...
Centogene NV to Host Earnings Call
10:00am, Thursday, 23'rd Apr 2020
NEW YORK, NY / ACCESSWIRE / April 23, 2020 / Centogene NV (NASDAQ:CNTG) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on April 23, 2020 at 8:00 AM Eas
CENTOGENE Releases a New Swab Product to Facilitate the Simple Diagnosis of COVID-19
03:00pm, Tuesday, 21'st Apr 2020
CENTOGENE (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp
The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision
09:22pm, Sunday, 19'th Apr 2020
Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17.Apart from the broader market sentiment, big moves in biopharma companies such as Johnson & Johnson (NYS
CENTOGENE and Ubirch Create Secure Blockchain Solution for the Successful Fight Against COVID-19
10:30am, Friday, 17'th Apr 2020
CENTOGENE (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp
CENTOGENE to Report Full Year 2019 Financial Results on April 23, 2020
03:24pm, Thursday, 16'th Apr 2020
CENTOGENE (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp
CENTOGENE Announces Opening of Laboratory in Hamburg, Germany
01:29pm, Wednesday, 15'th Apr 2020
CENTOGENE (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical comp
Centogene (NASDAQ:CNTG) vs. Guardant Health (NASDAQ:GH) Financial Analysis
05:44am, Thursday, 02'nd Apr 2020
Centogene (NASDAQ:CNTG) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, prof
Analyzing Laboratory Corp. of America (NYSE:LH) and Centogene (NYSE:CNTG)
07:36am, Wednesday, 25'th Mar 2020
Laboratory Corp. of America (NYSE:LH) and Centogene (NASDAQ:CNTG) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their divid
Coronavirus Scare Supports These Biotech ETFs & Stocks
12:00pm, Tuesday, 24'th Mar 2020
Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
CENTOGENE Announces Commencement of Testing for COVID-19
06:13pm, Wednesday, 18'th Mar 2020
CENTOGENE (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical compa
CENTOGENE Announces Changes in Supervisory Board
07:39pm, Tuesday, 17'th Mar 2020
CENTOGENE N.V. (CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical